Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
Condition(s):Ischemia Reperfusion Injury; Delayed Graft FunctionLast Updated:July 20, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Ischemia Reperfusion Injury; Delayed Graft FunctionLast Updated:July 20, 2023Recruiting
Condition(s):Living Donor Liver Transplantation; Reperfusion InjuryLast Updated:November 29, 2011Completed
Condition(s):Ischemia Reperfusion Injury; Cardiovascular DiseaseLast Updated:March 17, 2009Completed
Condition(s):Cardiovascular Disease; Ischemia-Reperfusion InjuryLast Updated:July 29, 2008Completed
Condition(s):Ischemia-Reperfusion Injury; AtherosclerosisLast Updated:April 15, 2008Completed
Condition(s):Ischemic PreconditioningLast Updated:April 3, 2019Unknown status
Condition(s):Ischemia Reperfusion Injury; Heart TransplantationLast Updated:June 18, 2013Withdrawn
Condition(s):Ischemia Reperfusion Injury; Endothelial DysfunctionLast Updated:April 28, 2010Completed
Condition(s):STEMI – ST Elevation Myocardial Infarction; Reperfusion Injury, MyocardialLast Updated:June 26, 2019Unknown status
Condition(s):Hepatectomy; Reperfusion InjuryLast Updated:June 8, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.